BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang HI, Lee MH, Liu J, Chen CJ. Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia. World J Gastroenterol 2014; 20(20): 6244-6251 [PMID: 24876745 DOI: 10.3748/wjg.v20.i20.6244]
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6244.htm
Number Citing Articles
1
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
2
Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Viral Hepatitis in Children2019; : 33 doi: 10.1007/978-981-13-0050-9_3
3
Chien-Jen Chen, Hwai-I Yang, Mei-Hsuan Lee, Jessica Liu, Hui-Han Hu. Hepatitis B Virus in Human DiseasesMolecular and Translational Medicine 2016; : 249 doi: 10.1007/978-3-319-22330-8_12
4
Hwai-I Yang, Tai-Chung Tseng, Jessica Liu, Mei-Hsuan Lee, Chun-Jen Liu, Tung-Hung Su, Richard Batrla-Utermann, Henry Lik-Yuen Chan, Jia-Horng Kao, Chien-Jen Chen. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisClinical Gastroenterology and Hepatology 2016; 14(3): 461 doi: 10.1016/j.cgh.2015.10.033
5
Nicolas Goossens, Yujin Hoshida. Personalized management of hepatocellular carcinoma based on molecular information: Future prospectsClinical Liver Disease 2015; 5(6): 132 doi: 10.1002/cld.483
6
Pedro Magalhães-Costa, Luís Lebre, Paula Peixe, Sofia Santos, Cristina Chagas. Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Third Generation Nucleos(t)ides Analogs: Risk Factors and Performance of a Risk ScoreGE Portuguese Journal of Gastroenterology 2016; 23(5): 233 doi: 10.1016/j.jpge.2016.02.001
7
Jessica Liu, Hui-Han Hu, Mei-Hsuan Lee, Masaaki Korenaga, Chin-Lan Jen, Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, Masashi Mizokami, Chien-Jen Chen, Hwai-I Yang. Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B PatientsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14747-5
8
Nicolas Goossens, Yujin Hoshida. Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futurasClinical Liver Disease 2016; 8(S1): S43 doi: 10.1002/cld.601
9
Hung-Chih Yang. Hepatitis B Virus and Liver Disease2018; : 119 doi: 10.1007/978-981-10-4843-2_6
10
Hui-Han Hu, Jessica Liu, Yu-Ling Lin, Wun-Sheng Luo, Yu-Ju Chu, Chia-Lin Chang, Chin-Lan Jen, Mei-Hsuan Lee, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Hwai-I Yang, Chien-Jen Chen. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis BGut 2016; 65(9): 1514 doi: 10.1136/gutjnl-2015-310686
11
Justin Chien, Jessica Liu, Mei‐Hsuan Lee, Chin‐Lan Jen, Richard Batrla‐Utermann, Sheng‐Nan Lu, Li‐Yu Wang, San‐Lin You, Hwai‐I Yang, Chien‐Jen Chen. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosisJournal of Gastroenterology and Hepatology 2016; 31(12): 1971 doi: 10.1111/jgh.13422
12
Hung-Chih Yang, Tung-Hung Su. Hepatitis B Virus and Liver Disease2021; : 205 doi: 10.1007/978-981-16-3615-8_9
13
Chien-Jen Chen, Mei-Hsuan Lee, Jessica Liu, Hwai-I Yang. Hepatocellular Carcinoma Risk Scores: Ready to Use in 2015?Hepatic Oncology 2015; 2(1): 1 doi: 10.2217/hep.14.32
14
Chih-Lin Lin, Jia-Horng Kao. Perspectives and control of hepatitis B virus infection in TaiwanJournal of the Formosan Medical Association 2015; 114(10): 901 doi: 10.1016/j.jfma.2015.06.003
15
ZHICHENG YAO, KUNPENG HU, HE HUANG, SHILEI XU, QINGLIANG WANG, PENG ZHANG, PEISHENG YANG, BO LIU. shRNA-mediated silencing of the RFC3 gene suppresses hepatocellular carcinoma cell proliferationInternational Journal of Molecular Medicine 2015; 36(5): 1393 doi: 10.3892/ijmm.2015.2350
16
Josh Hanson, Melissa Fox, Adam Anderson, Penny Fox, Kate Webster, Charlie Williams, Blake Nield, Richard Bagshaw, Allison Hempenstall, Simon Smith, Norma Solomon, Peter Boyd, Yury E Khudyakov. Chronic hepatitis B in remote, tropical Australia; successes and challengesPLOS ONE 2020; 15(9): e0238719 doi: 10.1371/journal.pone.0238719
17
Sahar Amirpour-Rostami, Mohammad Kazemi Arababadi. IL-18 and IL-1β Gene Polymorphisms: The Plausible Risk Factors for Chronic Hepatitis BViral Immunology 2019; 32(5): 208 doi: 10.1089/vim.2018.0155
18
Hwai-I Yang, Chien-Jen Chen. Hepatitis B Virus and Liver Disease2021; : 143 doi: 10.1007/978-981-16-3615-8_7
19
L.‐Y. Mak, D. K.‐H. Wong, K.‐S. Cheung, W.‐K. Seto, C.‐L. Lai, M.‐F. Yuen. Review article: hepatitis B core‐related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infectionAlimentary Pharmacology & Therapeutics 2018; 47(1): 43 doi: 10.1111/apt.14376
20
Chih‐Lin Lin, Tai‐Chung Tseng, Jia‐Horng Kao. What can we learn from hepatitis B virus clinical cohorts?Liver International 2015; 35(s1): 91 doi: 10.1111/liv.12716
21
Chien-Jen Chen, San-Lin You, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Hui-Chi Chen, Yun-Yuan Chen, Jessica Liu, Hui-Han Hu, Yu-Ju Lin, Yu-Ju Chu, Yen-Tsung Huang, Chun-Ju Chiang, Yin-Chu Chien. Viruses and Human CancerRecent Results in Cancer Research 2021; 217: 13 doi: 10.1007/978-3-030-57362-1_2